IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Structure Therapeutics Inc

CUSIP: 00864E110 | 2 institutional holders

Quarters

Q1 2026Q4 2025Q2 2025Q1 2025Q4 2024
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2026

Schroder Investment Management Group118,225
0.0% of portfolio›$5.2M
StyleTurnoverLocationFiled
Schroder Investment Management Group
118,225$5.2M0.0%CoreMediumLondon, United Kingdom2026-05-14